Salesforce vs ServiceNow: Buys Back or Buys Companies
Salesforce leans on a sweeping buyback to defend its core, while ServiceNow expands through acquisitions focused on s...
Year End Tax Forms For Etfs
A quick guide to the year-end tax forms required for ETFs and tips to ensure correct reporting on your return.
24,251 articles
Reason Tesla Stock Keep Underperforming: One Key Driver
Tesla fans and skeptics alike have watched the stock struggle even as leadership paints an upbeat picture. This artic...
Cramer Calls Broadcom Undervalued Amid AI Growth Rally
Jim Cramer declares Broadcom undervalued after a solid earnings quarter with AI revenue accelerating; investors weigh...
Lucid Diagnostics (LUCD) Earnings: Outlook and Analysis
Lucid Diagnostics (LUCD) is navigating reimbursement and adoption as it scales its non-invasive tests. This analysis ...
Comparison Chart of No Annual Fee Cashback Cards: 2026 Guide
Want the most cash back without paying an annual fee? This comparison chart of no annual fee cashback cards breaks do...
2023 Cash Back Rewards Cards with No Fees: Top No-fee Picks
No annual fee doesn’t mean low value. This guide highlights the best 2023 cash back rewards cards with no fees, plus ...
Micron vs Intel: Which Volatile Memory Stock to Buy Now
Micron's memory leadership and AI-ready HBM4 shipments clash with Intel's restructuring effort and foundry bets. As A...
Global Payments Stock Blasted Higher: Drivers and Outlook for Investors
Global Payments stunned the market with a strong earnings beat and optimistic guidance, triggering a sharp stock move...
Algonquin Power Utilities Stock Slumps After Guidance Miss
Friday brought a sharp move for algonquin power utilities stock as investors digested a guidance miss for 2027. This ...
Elanco (ELAN) 2026 Earnings: Key Investor Takeaways
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...
Why Kohl's Stock Crushed Today: A Closer Look at the Move
Kohl's stunned investors with a strong swing in its latest quarterly results, sending the stock higher by double digi...
Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status